Literature DB >> 26118419

Interaction exists between matriptase inhibitors and intestinal epithelial cells.

Erzsebet Pászti-Gere1, Réka Fanni Barna1, Gabriella Ujhelyi2, Torsten Steinmetzer3.   

Abstract

The type II trypsin-like transmembrane serine protease matriptase, is mainly expressed in epithelial cells and one of the key regulators in the formation and maintenance of epithelial barrier integrity. Therefore, we have studied the inhibition of matriptase in a non-transformed porcine intestinal IPEC-J2 cell monolayer cultured on polyester membrane inserts by the non-selective 4-(2-aminoethyl)-benzosulphonylfluoride (AEBSF) and four more selective 3-amidinophenylalanine-derived matriptase inhibitors. It was found that suppression of matriptase activity by MI-432 and MI-460 led to decreased transepithelial electrical resistance (TER) of the cell monolayer and to an enhanced transport of fluorescently labelled dextran, a marker for paracellular transport between apical and basolateral compartments. To this date this is the first report in which the inhibition of matriptase activity by synthetic inhibitors has been correlated to a reduced barrier integrity of a non-cancerous IPEC-J2 epithelial cell monolayer in order to describe interaction between matriptase activity and intestinal epithelium in vitro.

Entities:  

Keywords:  3-Amidinophenylalanine; IPEC-J2 cells; intestinal barrier integrity; matriptase inhibitors; paracellular permeability

Mesh:

Substances:

Year:  2015        PMID: 26118419     DOI: 10.3109/14756366.2015.1060483

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  5 in total

1.  The Effects of Matriptase Inhibition on the Inflammatory and Redox Homeostasis of Chicken Hepatic Cell Culture Models.

Authors:  Réka Fanni Barna; Máté Mackei; Erzsébet Pászti-Gere; Zsuzsanna Neogrády; Ákos Jerzsele; Gábor Mátis
Journal:  Biomedicines       Date:  2021-04-21

2.  Inhibition of Matriptase Activity Results in Decreased Intestinal Epithelial Monolayer Integrity In Vitro.

Authors:  E Pászti-Gere; S McManus; N Meggyesházi; P Balla; P Gálfi; T Steinmetzer
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

3.  Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier.

Authors:  Lorena M Coria; Gabriela S Risso; Francisco F Guaimas; Mariana C Ferrero; Laura Bruno; Karina A Pasquevich; Juliana Cassataro
Journal:  J Control Release       Date:  2018-11-27       Impact factor: 9.776

4.  Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect.

Authors:  Erzsébet Pászti-Gere; Judit Pomothy; Ákos Jerzsele; Oliver Pilgram; Torsten Steinmetzer
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  Reinforced Epithelial Barrier Integrity via Matriptase Induction with Sphingosine-1-Phosphate Did Not Result in Disturbances in Physiological Redox Status.

Authors:  E Pászti-Gere; Á Jerzsele; P Balla; G Ujhelyi; A Székács
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.